Living definition
What is Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1)?
Vaccines & ImmunotherapyBio, Health & Neuro
- As of
- 2026-09-22
- Revision
- 2026-10-06.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1) is an investigational messenger-RNA vaccine aimed at the Bundibugyo species of ebolavirus, a strain outside the coverage of the licensed ebolavirus vaccines. It instructs the recipient's cells to make a viral protein so the immune system learns to recognise that strain.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-22, verified readiness is 13 (claimed 15, reported 15, gap 2) — Strong evidence strength; current signals suggest Track; not yet.
The readiness fact belongs to the canonical Readiness Verdict for Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1).
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06